Industry

2022 Global Lung Cancer Clinical Trial Pipeline Highlights Report: Up-to-date Information on Key Pipeline Products – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Lung Cancer Clinical Trial Pipeline Highlights – 2022” report has been added to ResearchAndMarkets.com’s offering. This report provides the most up-to-date information on key pipeline products within the global Lung Cancer market. It covers emerging therapies for Lung Cancer in active clinical development stages including early and late stage clinical trials. The … [Read more…]

EVER Pharma Launches the User-friendly D-mine® Pump Generated Report “DATA-mine®” to Enhance the Therapy Management of Parkinson’s Patients on Apomorphine

SALZBURG, Austria–(BUSINESS WIRE)–#dminecare—After successfully launching the D-mine® Pump, a micro infusion device designed to provide precise continuous subcutaneous drug delivery for PD patients, the product family has been extended to include a comprehensive data history readout. EVER Pharma, a specialist in neurology and specialty pharmaceuticals, offers a complete therapy package for PD patients with Dacepton® … [Read more…]

Four out of ten Canadians report significant gap between culture their workplace claims to have versus their reality

Supported by TELUS Health, LifeWorks’ Mental Health Index™ finds negative workplace culture impacts mental health and leads to three times less productivity than positive environments TORONTO–(BUSINESS WIRE)–LifeWorks, a leading provider of digital and in-person total wellbeing solutions supported by TELUS Health, today released its monthly Mental Health Index™ revealing that four out of 10 (38 … [Read more…]

R&D Day: Presentations to Highlight Transgene’s Competitive Positioning, Capabilities to Engineer Novel Immunotherapies for Patients with Cancer, and Update on Initial Clinical Data

Meeting to highlight Company’s innovative portfolio, supported by updated clinical data, demonstrating the potential of therapeutic vaccine and oncolytic virus candidates to improve cancer patient outcomes STRASBOURG, France–(BUSINESS WIRE)–#HBV–Regulatory News: Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, will host today an R&D event for investors and … [Read more…]

ONWARD Reports First Half 2022 Financial and Operating Results

THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) Company also Provides Business Update and Reiterates 2022 Outlook Conference call and webcast (in English) today, September 27, 2022, at 4:00 PM CEST (3:00 PM BST/10:00 AM EDT) EINDHOVEN, the Netherlands & LAUSANNE, Switzerland & BOSTON–(BUSINESS … [Read more…]

BenevolentAI Interim Results for the Six Months Ended 30 June 2022

Continued operational progress and strengthened financial position provides capital for key value inflection points and continued investment in leading technology platform Full data expected in Q1 2023 for BEN-2293 Phase IIa clinical study; a potential treatment for atopic dermatitis and a topical, best-in-class PanTrk inhibitor Collaboration extended with AstraZeneca to four disease areas, now with … [Read more…]

Renovacor Announces Upcoming Presentation at Keystone Symposia’s Heart Failure: Mechanisms and Therapies Conference

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Renovacor, Inc. (NYSE: RCOR), a biotechnology company focused on delivering innovative precision therapies to improve the lives of patients and families battling genetically-driven cardiovascular and mechanistically-related diseases, today announced that preclinical studies characterizing the progression of cardiac dysfunction and mortality in a BAG3 haploinsufficiency mouse model of dilated cardiomyopathy will be featured in … [Read more…]

ICON plc Schedules Third Quarter 2022 Earnings Conference Call

DUBLIN–(BUSINESS WIRE)–ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organisation, today announced that it will release its financial results for the third quarter 2022 after the market closes on Wednesday, November 2, 2022. The company will hold a conference call and webcast to discuss its financial results and performance on Thursday, November … [Read more…]

Independent Proxy Advisory Firm ISS Recommends a Vote FOR the Zymeworks Redomicile

Institutional Shareholder Services joins Glass Lewis in recommending a vote FOR the Redomicile resolution ISS cites potential for improved capital raising ability and commercialization efficiencies for the Company’s lead product candidate, zanidatamab To vote, contact Kingsdale Advisors at 1-855-476-7981 (within North America) or at 1-416-867-2272 (outside North America), or at contactus@kingsdaleadvisors.com VANCOUVER, British Columbia & … [Read more…]

ONE LIFE Gala Raises Over $400,000 for the Princess Margaret Cancer Centre

The inaugural event honoured cancer survivors and raised funds for the Magic Castle TORONTO–(BUSINESS WIRE)–#BeWellAdvised–The inaugural ONE LIFE Gala in support of the Princess Margaret Cancer Centre announces it has raised over $400,000 for the Magic Castle, a play area for children of cancer patients undergoing treatment. Presented by the CI Assante Wealth Management Circle … [Read more…]